Viveve Treatment / Vagina Tightening
Viveve Treatment / Vagina Tightening
Just like skin, vaginal tissue is made up of collagen fibers. During vaginal childbirth these tissues can overstretch, damaging the collagen and creating a feeling of looseness (laxity), especially around the vaginal opening.
Women who experience this loss of tightness may also notice a decreased feeling of sensation and sexual satisfaction during intercourse. These changes can affect a woman’s overall sexual health and are a quality of life issue for millions of women every year.
In a survey of over 400 women who had vaginal deliveries, nearly half reported some level of concern with vaginal looseness, otherwise known as vaginal laxity.
While it may be a difficult subject to bring up with your doctor, your sexual health is an important part of your overall health and well-being, and worthy of a dialogue.
At Enhanze Aesthetics we put your wishes and needs first and to solve this problem for you we bring you this new non-surgical, painless, medical procedure which treats vaginal laxity and it also increases the amount of pleasurable friction and sensation during intercourse, this procedure is called the Viveve Treatment, it is not a cosmetic procedure, it’s not about how you look, but how you feel.
The Viveve Treatment is an alternative to surgery. A physician performs the treatment using the Viveve System that works by cooling and gently heating vaginal tissue at the cellular level which tightens the tissue at the vaginal opening from within, gently and gradually. The Viveve treatment involves just one 30-minute treatment, with no anesthesia and no downtime.
With just one treatment, the regenerative process is initiated, but full effect will build gradually over time, generally between 30 and 90 days. In clinical trials to date, 90% of the women treated reported significant, sustained tightening at 12 months after treatment, with an average improvement of 68%.
Imagine how one safe, painless, 30-minute Viveve treatment can have a sensational impact on your sexual enjoyment. Call us for an appointment and discuss with our doctor whether the Viveve procedure is right for you.
Viveve Treatment / Vagina Tightening Q&A
Viveve is a new non-surgical medical procedure for treating vaginal laxity. The 30-minute procedure does not require any anesthesia or analgesics and is performed by a trained physician in an outpatient setting. The Viveve System uses radiofrequency energy to stimulate the body’s collagen formation processes, which leads to increased vaginal tightness and can improve sexual satisfaction.
The Viveve Treatment is the only clinically proven and effective, non-surgical procedure specifically designed for vaginal introital laxity. There is little to no downtime and the patient can return to normal activities immediately following the procedure.
Two clinical studies have been published in the Journal of Sexual Medicine and the Journal of Women’s Health. Results analyzed from studies done with a total of 54 in the U.S. and Japan Studies showed statistically significant improvement in vaginal tightness, to pre-childbirth levels, at 1, 3, 6, and 12 months following treatment. At 12 months, improved and sustained tightness was shown by 88% of the women. Significant improvement in sexual satisfaction was indicated through 12 month follow-up. These results were achieved after a single, painless, office-based Viveve Procedure.
Who should consider having the Viveve Treatment?
The Viveve Treatment is contraindicated for patients with either an implantable pacemaker or an AICD (Automatic Implantable Cardioverter/Defibrillator) or any other implantable device as they may be adversely affected by radiofrequency (RF) fields or current.
Side effects seldom occur and are typically mild, temporary, and resolve shortly after treatment. They can include: slight, white vaginal discharge; redness or swelling; slight abdominal discomfort, focal, transient altered sensation and tingling following treatment.
In rare cases, a Viveve patient could develop an infection requiring antibiotics. Although no permanent complications have been reported to date, there is a remote possibility of damage to the urethra or rectum.